Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 9601349, 12 pages
https://doi.org/10.1155/2017/9601349
Research Article

MicroRNA-146a Alleviates Experimental Autoimmune Anterior Uveitis in the Eyes of Lewis Rats

1Department of Ophthalmology, Far Eastern Memorial Hospital, No. 21, Sec. 2, Nanya South Road, Banqiao, New Taipei City 22056, Taiwan
2Department of Ophthalmology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10002, Taiwan
3College of Medicine, National Taiwan University, No. 7, Chung-Shan South Road, Taipei 10002, Taiwan

Correspondence should be addressed to Chang-Hao Yang; wt.ude.utn@hpognayhc

Received 16 August 2017; Accepted 12 November 2017; Published 24 December 2017

Academic Editor: Ronald Gladue

Copyright © 2017 Yung-Ray Hsu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Gritz and I. G. Wong, “Incidence and prevalence of uveitis in Northern California: the Northern California epidemiology of uveitis study,” Ophthalmology, vol. 111, no. 3, pp. 491–500, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Llorenc, M. Mesquida, M. Sainz de la Maza et al., “Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization,” Acta Ophthalmologica, vol. 93, no. 6, pp. 561–567, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Miserocchi, G. Fogliato, G. Modorati, and F. Bandello, “Review on the worldwide epidemiology of uveitis,” European Journal of Ophthalmology, vol. 23, no. 5, pp. 705–717, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. D. Dick, N. Tundia, R. Sorg et al., “Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis,” Ophthalmology, vol. 123, no. 3, pp. 655–662, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. D. K. Hwang, Y. J. Chou, P. CY, and P. Chou, “Risk factors for developing glaucoma among patients with uveitis: a nationwide study in Taiwan,” Journal of Glaucoma, vol. 24, no. 3, pp. 219–224, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Gaujoux-Viala, C. Giampietro, T. Gaujoux et al., “Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye disease,” The Journal of Rheumatology, vol. 39, no. 2, pp. 233–239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Uchiyama, G. N. Papaliodis, A. M. Lobo, and L. Sobrin, “Side-effects of anti-inflammatory therapy in uveitis,” Seminars in Ophthalmology, vol. 29, no. 5-6, pp. 456–467, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. R. M. Broekhuyse, E. D. Kuhlmann, H. J. Winkens, and A. H. Van Vugt, “Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis. I. Induction by a detergent-insoluble, intrinsic protein fraction of the retinal pigment epithelium,” Experimental Eye Research, vol. 52, no. 4, pp. 465–474, 1991. View at Publisher · View at Google Scholar · View at Scopus
  9. I. M. Fang, C. P. Lin, C. M. Yang, M. S. Chen, and C. H. Yang, “Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis,” Molecular Vision, vol. 11, pp. 443–451, 2005. View at Google Scholar
  10. Y. Sakoda, T. Nagai, S. Murata et al., “Pathogenic function of herpesvirus entry mediator in experimental autoimmune uveitis by induction of Th1- and Th17-type T cell responses,” The Journal of Immunology, vol. 196, no. 7, pp. 2947–2954, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. R. Hsu, S. W. Chang, Y. C. Lin, and C. H. Yang, “Expression of microRNAs in the eyes of Lewis rats with experimental autoimmune anterior uveitis,” Mediators of Inflammation, vol. 2015, Article ID 457835, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Shoda, R. Yanai, T. Yoshimura et al., “Dietary omega-3 fatty acids suppress experimental autoimmune uveitis in association with inhibition of Th1 and Th17 cell function,” PLoS One, vol. 10, no. 9, article e0138241, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. C. H. Yang, I. M. Fang, C. P. Lin, C. M. Yang, and M. S. Chen, “Effects of the NF-κB inhibitor pyrrolidine dithiocarbamate on experimentally induced autoimmune anterior uveitis,” Investigative Ophthalmology & Visual Science, vol. 46, no. 4, pp. 1339–1347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Sun, D. Liang, H. J. Kaplan, and H. Shao, “The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU),” Cytokine, vol. 74, no. 1, pp. 76–80, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. B. J. Kroesen, N. Teteloshvili, K. Smigielska-Czepiel et al., “Immuno-miRs: critical regulators of T-cell development, function and ageing,” Immunology, vol. 144, no. 1, pp. 1–10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. L. LF and A. Liston, “MicroRNA in the immune system, microRNA as an immune system,” Immunology, vol. 127, no. 3, pp. 291–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Xiao and K. Rajewsky, “MicroRNA control in the immune system: basic principles,” Cell, vol. 136, no. 1, pp. 26–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. P. Boldin, K. D. Taganov, D. S. Rao et al., “miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice,” The Journal of Experimental Medicine, vol. 208, no. 6, pp. 1189–1201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. K. D. Taganov, M. P. Boldin, K. J. Chang, and D. Baltimore, “NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 33, pp. 12481–12486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Kaneko, G. S. Wu, S. Saraswathy, D. V. Vasconcelos-Santos, and N. A. Rao, “Immunopathologic processes in sympathetic ophthalmia as signified by microRNA profiling,” Investigative Ophthalmology & Visual Science, vol. 53, no. 7, pp. 4197–4204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Ishida, K. Fukuda, T. Higuchi, M. Kajisako, S. Sakamoto, and A. Fukushima, “Dynamic changes of microRNAs in the eye during the development of experimental autoimmune uveoretinitis,” Investigative Ophthalmology & Visual Science, vol. 52, no. 1, pp. 611–617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Watanabe, H. Keino, A. Kudo, Y. Sato, and A. A. Okada, “MicroRNAs in retina during development of experimental autoimmune uveoretinitis in rats,” British Journal of Ophthalmology, vol. 100, no. 3, pp. 425–431, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Zhang, Y. W. Qin, G. Brewer, and Q. Jing, “MicroRNA degradation and turnover: regulating the regulators,” Wiley Interdisciplinary Reviews: RNA, vol. 3, no. 4, pp. 593–600, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. P. Gantier, C. E. McCoy, I. Rusinova et al., “Analysis of microRNA turnover in mammalian cells following Dicer1 ablation,” Nucleic Acids Research, vol. 39, no. 13, pp. 5692–5703, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Feng, S. Chen, K. McArthur et al., “miR-146a-mediated extracellular matrix protein production in chronic diabetes complications,” Diabetes, vol. 60, no. 11, pp. 2975–2984, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Saxena and J. Kaur, “Th1/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinoma,” World Journal of Hepatology, vol. 7, no. 11, pp. 1572–1580, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Chen and J. J. O'Shea, “Th17 cells: a new fate for differentiating helper T cells,” Immunologic Research, vol. 41, no. 2, pp. 87–102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. P. Boldin and D. Baltimore, “MicroRNAs, new effectors and regulators of NF-κB,” Immunological Reviews, vol. 246, no. 1, pp. 205–220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Nahid, K. M. Pauley, M. Satoh, and E. K. Chan, “miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity,” The Journal of Biological Chemistry, vol. 284, no. 50, pp. 34590–34599, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. B. S. Cobb, A. Hertweck, J. Smith et al., “A role for Dicer in immune regulation,” The Journal of Experimental Medicine, vol. 203, no. 11, pp. 2519–2527, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Smigielska-Czepiel, A. van den Berg, P. Jellema et al., “Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs,” Genes & Immunity, vol. 15, no. 2, pp. 115–125, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Wang, X. Zhang, Y. Ju et al., “MicroRNA-146a feedback suppresses T cell immune function by targeting Stat1 in patients with chronic hepatitis B,” The Journal of Immunology, vol. 191, no. 1, pp. 293–301, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Niimoto, T. Nakasa, M. Ishikawa et al., “MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients,” BMC Musculoskeletal Disorders, vol. 11, no. 1, p. 209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Nakasa, S. Miyaki, A. Okubo et al., “Expression of microRNA-146 in rheumatoid arthritis synovial tissue,” Arthritis & Rheumatism, vol. 58, no. 5, pp. 1284–1292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Yang, M. P. Boldin, Y. Yu et al., “miR-146a controls the resolution of T cell responses in mice,” The Journal of Experimental Medicine, vol. 209, no. 9, pp. 1655–1670, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Curtale, F. Citarella, C. Carissimi et al., “An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes,” Blood, vol. 115, no. 2, pp. 265–273, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Park, W. J. Lee, and J. D. Ji, “Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: a meta-analysis,” Autoimmunity, vol. 49, no. 7, pp. 451–458, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Li, C. Du, W. Wang et al., “Genetic association of miR-146a with multiple sclerosis susceptibility in the Chinese population,” Cellular Physiology and Biochemistry, vol. 35, no. 1, pp. 281–291, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Zhang, X. Yi, S. Guo et al., “A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study,” Journal of Cellular and Molecular Medicine, vol. 18, no. 11, pp. 2225–2234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. Q. Zhou, S. Hou, L. Liang et al., “MicroRNA-146a and Ets-1 gene polymorphisms in ocular Behçet’s disease and Vogt-Koyanagi-Harada syndrome,” Annals of the Rheumatic Diseases, vol. 73, no. 1, pp. 170–176, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Wei, Q. Zhou, S. Hou et al., “MicroRNA-146a and Ets-1 gene polymorphisms are associated with pediatric uveitis,” PLoS One, vol. 9, no. 3, article e91199, 2014. View at Publisher · View at Google Scholar · View at Scopus